The tool helps scientists understand how single-letter mutations and distant DNA regions influence gene activity, shaping ...
U.S. drugmaker Eli Lilly signed an agreement worth up to $1.12 billion with Seamless Therapeutics, the Germany-based startup ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results